Table 3- Trials relating to podophyllotoxin
Reference |
Patients |
Design |
Clearance |
Recurrence |
Lacey et al 200313
|
358 |
Randomized controlled |
Compares podophyllotoxin solution, podophyllotoxin cream, and podophyllin. Podophyllotoxin showed greater efficacy and cost effectiveness than clinic based treatment with podophyllin. |
No data |
Tyring S et al, 1998 15 |
326 |
Double-blind, randomized trial |
After 8 weeks, 64% treated with 0.5% podofilox gel were cleared versus 12% in the vehicle-treated group. The 0.5% podofilox gel was generally well tolerated, with predominantly mild or moderate local reactions |
No data |
Claesson et al 1996 16 |
|
Randomized prospective study
|
Compared podophyllotoxin cream 0.15% and 0.3% versus 0.5% solution, showing no statistically significant differences between the 3 treatments with regard to both efficacy and safety. |
No data |
Bonnez W, et al, 1994 17 |
103 |
Randomized Controlled Trial |
Showing efficacy and tolerance of 0.5% podofilox in the treatment of anogenital warts. |
Podophyllotoxin is superior when patient-administered over the vehicle alone as prophylaxis against recurrence of lesions. |